European Journal Of Clinical Pharmacology

European Journal Of Clinical Pharmacology英文簡介

The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.

Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.

Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves

-a compound that is interesting and new in some basic or fundamental way, or

-methods that are original in some basic sense, or

-a highly unexpected outcome, or

-conclusions that are scientifically novel in some basic or fundamental sense.

European Journal Of Clinical Pharmacology中文簡介

《European Journal Of Clinical Pharmacology》是一本由SPRINGER HEIDELBERG出版商出版的專業醫學期刊，該刊創刊于1968年，刊期Monthly，該刊已被國際權威數據庫SCI、SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 3區，小類學科：藥學 3區；在JCR（Journal Citation Reports）分區等級為Q3。該刊發文范圍涵蓋藥學等領域，旨在及時、準確、全面地報道國內外藥學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為3.064，平均審稿速度一般,3-8周。

中科院分區最新升級版（當前數據版本：2021年12月最新升級版）

大類學科	分區	小類學科	分區	Top期刊	綜述期刊
醫學	3區	PHARMACOLOGY & PHARMACY 藥學	3區	否	否

JCR分區（當前數據版本：2021-2022年最新版）

JCR分區等級	JCR所屬學科	分區	影響因子
Q3	PHARMACOLOGY & PHARMACY	Q3	3.064

期刊指數

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
3.064	99	27.78%	73.51%	未開放	一般,3-8周

IF值(影響因子)趨勢圖